558 related articles for article (PubMed ID: 18639296)
1. Effect of vardenafil on blood pressure profile of patients with erectile dysfunction concomitantly treated with doxazosin gastrointestinal therapeutic system for benign prostatic hyperplasia.
Ng CF; Wong A; Cheng CW; Chan ES; Wong HM; Hou SM
J Urol; 2008 Sep; 180(3):1042-6. PubMed ID: 18639296
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous administration of vardenafil and tamsulosin does not induce clinically significant hypotension in patients with benign prostatic hyperplasia.
Auerbach SM; Gittelman M; Mazzu A; Cihon F; Sundaresan P; White WB
Urology; 2004 Nov; 64(5):998-1003; discussion 1003-4. PubMed ID: 15533493
[TBL] [Abstract][Full Text] [Related]
3. [Doxazosin in the gastrointestinal therapeutic system (GITS) and doxazosin standard in patients with benign prostatic hyperplasia. Double-blind trial of efficacy and tolerability].
Gratzke P; Kirby RS
Fortschr Med Orig; 2000 Jul; 118 Suppl 2():83-92. PubMed ID: 15700491
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of vardenafil for the treatment of erectile dysfunction in men with hypertension: a meta-analysis of clinical trial data.
Shabsigh R; Duval S; Shah M; Regan TS; Juhasz M; Veltry LG
Curr Med Res Opin; 2007 Oct; 23(10):2453-60. PubMed ID: 17727740
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy and safety of oral vardenafil in the treatment of erectile dysfunction].
Pan T; Zhuang S; Ma H; Hong K; Tang W
Zhonghua Nan Ke Xue; 2004 Dec; 10(12):955-9. PubMed ID: 15638033
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of extended-release doxazosin and doxazosin standard in patients with concomitant benign prostatic hyperplasia and sexual dysfunction.
Kirby RS; O'Leary MP; Carson C
BJU Int; 2005 Jan; 95(1):103-9; discussion 109. PubMed ID: 15638905
[TBL] [Abstract][Full Text] [Related]
7. Extended duration of efficacy of vardenafil when taken 8 hours before intercourse: a randomized, double-blind, placebo-controlled study.
Porst H; Sharlip ID; Hatzichristou D; Rubio-Aurioles E; Gittelman M; Stancil BN; Smith PM; Wilkins HJ; Pommerville P;
Eur Urol; 2006 Nov; 50(5):1086-94; discussion 1094-5. PubMed ID: 16820261
[TBL] [Abstract][Full Text] [Related]
8. Vardenafil 20-mg demonstrated superior efficacy to 10-mg in Japanese men with diabetes mellitus suffering from erectile dysfunction.
Ishii N; Nagao K; Fujikawa K; Tachibana T; Iwamoto Y; Kamidono S
Int J Urol; 2006 Aug; 13(8):1066-72. PubMed ID: 16903931
[TBL] [Abstract][Full Text] [Related]
9. The effects of tamsulosin and sildenafil in separate and combined regimens on detailed hemodynamics in patients with benign prostatic enlargement.
Nieminen T; Tammela TL; Kööbi T; Kähönen M
J Urol; 2006 Dec; 176(6 Pt 1):2551-6. PubMed ID: 17085157
[TBL] [Abstract][Full Text] [Related]
10. Vardenafil improves ejaculation success rates and self-confidence in men with erectile dysfunction due to spinal cord injury.
Giuliano F; Rubio-Aurioles E; Kennelly M; Montorsi F; Kim ED; Finkbeiner AE; Pommerville PJ; Colopy MW; Wachs BH;
Spine (Phila Pa 1976); 2008 Apr; 33(7):709-15. PubMed ID: 18379396
[TBL] [Abstract][Full Text] [Related]
11. Penetration and maintenance of erection with vardenafil: a time-from-dosing analysis.
Valiquette L; Montorsi F; Hellstrom WJ; Giuliano F; Homering M; Taylor T; Eardley I;
Can J Urol; 2005 Jun; 12(3):2687-98; discussion 2699. PubMed ID: 16011816
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of vardenafil for kidney transplant recipients with erectile dysfunction].
Yang J; Ju W; Zeng FQ; Xiao YJ; Zhang XP; Xiao CG
Zhonghua Nan Ke Xue; 2008 Oct; 14(10):911-3. PubMed ID: 19157102
[TBL] [Abstract][Full Text] [Related]
13. Improvement in erectile function on vardenafil treatment correlates with treatment satisfaction in both patients and their partners.
Ralph D; Eardley I; Kell P; Dean J; Hackett G; Collins O; Edwards D
BJU Int; 2007 Jul; 100(1):130-6. PubMed ID: 17488308
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular parameter changes in patients with erectile dysfunction using pde-5 inhibitors: a study with sildenafil and vardenafil.
Pomara G; Morelli G; Pomara S; Taddei S; Ghiadoni L; Dinelli N; Travaglini F; Dicuio M; Mondaini N; Salvetti A; Selli C
J Androl; 2004; 25(4):625-9. PubMed ID: 15223851
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, placebo-controlled, randomized clinical study of the effects of vardenafil on human nasal patency.
Aydin E; Hizal E; Onay O; Ozgen B; Turhan B; Zaimoglu M; Peskircioglu L; Budakoglu II
Am J Rhinol; 2008; 22(3):276-9. PubMed ID: 18588760
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up study to evaluate the efficacy and safety of the doxazosin gastrointestinal therapeutic system in patients with benign prostatic hyperplasia with or without concomitant hypertension.
Chung BH; Hong SJ
BJU Int; 2006 Jan; 97(1):90-5. PubMed ID: 16336335
[TBL] [Abstract][Full Text] [Related]
17. The COUPLES-project: a pooled analysis of patient and partner treatment satisfaction scale (TSS) outcomes following vardenafil treatment.
Rosen RC; Fisher WA; Beneke M; Homering M; Evers T
BJU Int; 2007 Apr; 99(4):849-59. PubMed ID: 17378845
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of tamsulosin hydrochloride compared to doxazosin in the treatment of Indonesian patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
Rahardjo D; Soebadi DM; Sugandi S; Birowo P; Djati W; Wahyudi I
Int J Urol; 2006 Nov; 13(11):1405-9. PubMed ID: 17083392
[TBL] [Abstract][Full Text] [Related]
19. A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.
Stief CG; Porst H; Neuser D; Beneke M; Ulbrich E
Eur Urol; 2008 Jun; 53(6):1236-44. PubMed ID: 18281145
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic interaction between a daily dosed phosphodiesterase 5 inhibitor, tadalafil, and the alpha-adrenergic blockers, doxazosin and tamsulosin, in middle-aged healthy male subjects.
Guillaume M; Lonsdale F; Darstein C; Jimenez MC; Mitchell MI
J Clin Pharmacol; 2007 Oct; 47(10):1303-10. PubMed ID: 17906163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
